Tesis Biosciences: Pharmacogenomics Test
Apr 20, 2023
Tesis Biosciences has launched a new pharmacogenomics test that it says will help physicians prescribe appropriate drugs and dosages for hundreds of diseases and conditions. According to the company, the new test can predict drug interactions for thousands of drugs, including those to treat common diseases like cancer, depression, diabetes, high blood pressure, and chronic pain. The test uses genetic data along with a proprietary software platform. Tesis said it will apply for US Food and Drug Administration approval for the test.